FDA Import Refusal AEK-0861603-8/30002/1 — Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited — FEI 3005757050

The FDA refused shipment AEK-0861603-8/30002/1 from Glenmark Pharmaceuticals Limited (India) on July 10, 2026. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 27 This firm has 5 or more other import refusals on record.

Refusal Details

Date
July 10, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
62OCY09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
Charges
27